In the European Association for the Study of the Liver (EASL), ANA, anti-SMA, anti-LKM1, anti-LC-1, anti-SLA/LP, p-ANCA, anti-LKM3, anti-Ro-52, anti-gp210, and anti-Sp100 are included in a case-based algorithm for patients with suspected AIH or drug-induced liver injury [16]. Here, SLA is linked to autoimmune hepatitis.